PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.09. PURE Bioscience shares last traded at $0.09, with a volume of 47,925 shares traded.
PURE Bioscience Price Performance
The firm has a 50 day moving average price of $0.07 and a 200-day moving average price of $0.08. The firm has a market capitalization of $10.07 million, a price-to-earnings ratio of -2.25 and a beta of 0.35.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its earnings results on Monday, March 17th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.39 million for the quarter.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- How to Find Undervalued Stocks
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- ESG Stocks, What Investors Should Know
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Best Stocks Under $10.00
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
